Association of a calcium channel blocker and diuretic prescribing cascade with adverse events: A population-based cohort study

被引:4
|
作者
Rochon, Paula A. [1 ,2 ,3 ,4 ,5 ,11 ]
Austin, Peter C. [3 ,5 ]
Normand, Sharon-Lise [6 ,7 ]
Savage, Rachel D. [1 ,2 ,3 ,5 ]
Read, Stephanie H. [1 ,2 ]
Mccarthy, Lisa M. [1 ,2 ,8 ,9 ]
Giannakeas, Vasily [1 ,2 ,3 ]
Wu, Wei [1 ,2 ]
Strauss, Rachel [3 ]
Wang, Xuesong [3 ]
Chen, Simon [3 ]
Gurwitz, Jerry H. [10 ]
机构
[1] Womens Coll Hosp, Womens Age Lab, Toronto, ON, Canada
[2] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada
[3] ICES, Toronto, ON, Canada
[4] Univ Toronto, Dept Med, Toronto, ON, Canada
[5] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[6] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA
[7] Harvard Sch Publ Hlth, Dept Biostat, Boston, MA USA
[8] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[9] Trillium Hlth Partners, Inst Better Hlth, Mississauga, ON, Canada
[10] UMass Chan Med Sch, Div Geriatr Med, Worcester, MA USA
[11] Univ Toronto, Womens Coll Hosp, Geriatr Med, Womens Age Lab, 76 Grenville St, Toronto, ON M5S 1B2, Canada
基金
加拿大健康研究院;
关键词
older adults; prescribing cascade; serious adverse events; EMERGENCY-DEPARTMENT VISITS; DRUG EVENTS; PEOPLE;
D O I
10.1111/jgs.18683
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
BackgroundPrescribing cascades occur when a drug adverse event is misinterpreted as a new medical condition and a second, potentially unnecessary drug, is prescribed to treat the adverse event. The population-level consequences of prescribing cascades remain unknown.MethodsThis population-based cohort study used linked health administrative databases in Ontario, Canada. The study included community-dwelling adults, 66 years of age or older with hypertension and no history of heart failure (HF) or diuretic use in the prior year, newly dispensed a calcium channel blocker (CCB). Individuals subsequently dispensed a diuretic within 90 days of incident CCB dispensing were classified as the prescribing cascade group, and compared to those not dispensed a diuretic, classified as the non-prescribing cascade group. Those with and without a prescribing cascade were matched one-to-one on the propensity score and sex. The primary outcome was a serious adverse event (SAE), which was the composite of emergency room visits and hospitalizations in the 90-day follow-up period. We estimated hazard ratios (HRs) with 95% confidence intervals (CI) for SAE using an Andersen-Gill recurrent events regression model.ResultsAmong 39,347 older adults with hypertension and no history of HF who were newly dispensed a CCB, 1881 (4.8%) had a new diuretic dispensed within 90 days after CCB initiation. Compared to the non-prescribing cascade group, those in the prescribing cascade group had higher rates of SAEs (HR: 1.21, 95% CI: 1.02-1.43).ConclusionsThe CCB-diuretic prescribing cascade was associated with an increased rate of SAEs, suggesting harm beyond prescribing a second drug therapy. Our study raises awareness of the downstream impact of the CCB-diuretic prescribing cascade at a population level and provides an opportunity for clinicians who identify this prescribing cascade to review their patients' medications to determine if they can be optimized.
引用
收藏
页码:467 / 478
页数:12
相关论文
共 50 条
  • [1] Evaluating Provider and Pharmacy Discordance in Potential Calcium Channel Blocker–Loop Diuretic Prescribing Cascade
    Asinamai M. Ndai
    Earl J. Morris
    Almut G. Winterstein
    Scott M. Vouri
    Drugs & Aging, 2024, 41 : 177 - 186
  • [2] Postdiagnostic Calcium Channel Blocker Use and Breast Cancer Mortality A Population-based Cohort Study
    Busby, John
    Mills, Ken
    Zhang, Shu-Dong
    Liberante, Fabio Giuseppe
    Cardwell, Chris R.
    EPIDEMIOLOGY, 2018, 29 (03) : 407 - 413
  • [3] Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker-diuretic prescribing cascade
    Singh, Sonal
    Cocoros, Noelle M.
    Haynes, Kevin
    Nair, Vinit P.
    Harkins, Thomas P.
    Rochon, Paula A.
    Platt, Richard
    Dashevsky, Inna
    Reynolds, Juliane
    Mazor, Kathleen M.
    Bloomstone, Sarah
    Anzuoni, Kathryn
    Crawford, Sybil L.
    Gurwitz, Jerry H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (08) : 1066 - 1073
  • [4] Evaluating Provider and Pharmacy Discordance in Potential Calcium Channel Blocker-Loop Diuretic Prescribing Cascade
    Ndai, Asinamai M.
    Morris, Earl J.
    Winterstein, Almut G.
    Vouri, Scott M.
    DRUGS & AGING, 2024, 41 (02) : 177 - 186
  • [5] An evaluation of a potential calcium channel blocker-lower-extremity edema-loop diuretic prescribing cascade
    Vouri, Scott Martin
    van Tuyl, Joseph S.
    Olsen, Margaret A.
    Xian, Hong
    Schootman, Mario
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2018, 58 (05) : 534 - +
  • [6] Prevalence and Factors Associated with a Potential Calcium Channel Blocker - Lower Extremity Edema - Loop Diuretic Prescribing Cascade
    Vouri, S. M.
    Van Tuyl, J.
    Olsen, M. A.
    Xian, H.
    Schootman, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S136 - S137
  • [7] Lack of association between vitiligo and major adverse cardiovascular events: A population-based cohort study
    Wu, Po-Chien
    Ma, Sheng-Hsiang
    Wu, Chun-Ying
    Pan, Tzu-Yun
    Chang, Yun-Ting
    Wu, Chen-Yi
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (06) : E773 - E775
  • [8] Association of Bipolar Disorder With Major Adverse Cardiovascular Events: A Population-Based Historical Cohort Study
    Foroughi, Moein
    Medina Inojosa, Jose R.
    Lopez-Jimenez, Francisco
    Saeidifard, Farzane
    Suarez, Laura
    Stokin, Gorazd B.
    Prieto, Miguel L.
    Rocca, Walter A.
    Frye, Mark A.
    Morgan, Robert J.
    PSYCHOSOMATIC MEDICINE, 2022, 84 (01): : 97 - 103
  • [9] NSAID prescribing and adverse outcomes in common infections: a population-based cohort study
    Stuart, Beth
    Venekamp, Roderick
    Hounkpatin, Hilda
    Wilding, Sam
    Moore, Michael
    Little, Paul
    Gulliford, Martin C.
    BMJ OPEN, 2024, 14 (01):
  • [10] Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers A Nationwide Population-Based Study
    Wang, Yi-Chun
    Hsieh, Tsung-Cheng
    Chou, Chu-Lin
    Wu, Jung-Lun
    Fang, Te-Chao
    MEDICINE, 2016, 95 (02)